Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
biosimilars
Pharma
Trump's tariffs, Leqembi, Kyowa Kirin—Fierce Pharma Asia
U.S. pharma tariffs are expected "in the next months or two." Leqembi won approval in the EU. Kyowa Kirin completed a biologics plant. And more.
Angus Liu
Apr 18, 2025 9:25am
Sandoz has filed a lawsuit against Amgen and its Enbrel patents
Apr 14, 2025 11:20am
J&J sues Samsung Bioepis over Stelara biosimilar agreement
Feb 25, 2025 10:21am
Biogen places chips behind 4 new drugs as MS competition mounts
Feb 12, 2025 11:35am
With biosim sales up 16%, Amgen expects another boost in 2025
Feb 5, 2025 11:28am
CHMP endorses host of new meds, reevaluates Leqembi
Jan 31, 2025 11:16am
.jpg?VersionId=DJwcxHE5JQuR0F0uscas79Jdn8HDPoqX)
